| (210) | Number of the EPO application | 16756953 |
| (220) | Filing date of the EPO application | 2016.08.01 |
| (80) | EPO patent specification publication (B) | EPB nr. 13/2021, 2021.03.31 |
| (110) | EPO patent number | 3328892 |
| (21) | Number of the application | e 2018 0565 |
| (71) | Name(s) of applicant(s), code of the country | Amgen Research (Munich) GmbH, DE; |
| (72) | Name(s) of inventor(s), code of the country | RAUM Tobias, DE;
KUFER Peter, DE;
RAU Doris, DE;
MUENZ Markus, DE;
HERRMANN Ines, DE;
HOFFMANN Patrick, DE;
BROZY Johannes, DE;
FRIEDRICH Matthias, DE;
RATTEL Benno, DE;
BOGNER Pamela, DE;
WOLF Andreas, DE;
POMPE Cornelius, DE; |
| (73) | Name(s) of owner(s), code of the country | AMGEN Research (Munich) GmbH, DE; |
| (54) | Title of the invention | BISPECIFIC ANTIBODY CONSTRUCTS BINDING EGFRVIII AND CD3 |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07K 16/28 (2006.01.01); C07K 16/46 (2006.01.01); A61K 39/395 (2006.01.01); A61P 35/00 (2006.01.01); A61P 35/04 (2006.01.01) |
| (19) | Country | DE |
| (41) | Date of publication of the application | 2018.07.31 |
| (30) | Priority | 201562199945 P, 2015.07.31, US; 201662290861 P, 2016.02.03, US |
| (86) | International application | PCT/EP2016/068332, 2016.08.01 |
| (87) | International publication | WO 2017/021370, 2017.02.09 |